{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:56:07Z","timestamp":1791906967271,"version":"4.3.4"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008663","name":"Health and Environmental Sciences Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.yrtph.2025.105971","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T06:45:25Z","timestamp":1761288325000},"page":"105971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Minimizing use of nonhuman primates to inform risk to fertility and of adverse pregnancy outcomes with pharmaceuticals"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2425-2603","authenticated-orcid":false,"given":"Christopher J.","family":"Bowman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diann L.","family":"Blanset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly C.","family":"Brannen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9101-7921","authenticated-orcid":false,"given":"Gary J.","family":"Chellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Enright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5060-6874","authenticated-orcid":false,"given":"Wendy","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany R.","family":"Hannas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushige","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2070-482X","authenticated-orcid":false,"given":"Fumito","family":"Mikashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7157-3768","authenticated-orcid":false,"given":"Shermaine","family":"Mitchell-Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Mylchreest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5295-2220","authenticated-orcid":false,"given":"Manjunatha K.","family":"Nanjappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8700-7226","authenticated-orcid":false,"given":"Helen","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puck","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Stanislaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela R.","family":"Stermer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"van Cruchten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.K.","family":"van Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin D.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9593-3572","authenticated-orcid":false,"given":"Ronald L.","family":"Wange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Theunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2025.105971_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105327","article-title":"FDA and industry collaboration: identifying opportunities to further reduce reliance on nonhuman primates for nonclinical safety evaluations","volume":"138","author":"Ackley","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0031-9384(85)90262-8","article-title":"Psychosocial influences on ovarian endocrine and ovulatory function in Macaca fascicularis","volume":"35","author":"Adams","year":"1985","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.yrtph.2025.105971_bib3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/toxsci\/kfu017","article-title":"Fishing for teratogens: a consortium effort for a harmonized zebrafish developmental toxicology assay","volume":"139","author":"Ball","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105971_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vascn.2011.12.001","article-title":"Developmental and reproductive toxicity testing of vaccines","volume":"65","author":"Barrow","year":"2012","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.yrtph.2025.105971_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2024.108727","article-title":"Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2022 and 2023","volume":"130","author":"Barrow","year":"2024","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1472-6483(10)60346-X","article-title":"Differential expression of follicular fluid cytokines: relationship to subsequent pregnancy in IVF cycles","volume":"15","author":"Bedaiwy","year":"2007","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.yrtph.2025.105971_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/bdrb.20281","article-title":"ILSI\/HESI maternal toxicity workshop summary: maternal toxicity and its impact on study design and data interpretation","volume":"92","author":"Beyer","year":"2011","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib8","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40744-021-00313-z","article-title":"Rituximab and canakinumab use during lactation: no detectable serum levels in breastfed infants","volume":"8","author":"Bosshard","year":"2021","journal-title":"Rheumatol Ther."},{"key":"10.1016\/j.yrtph.2025.105971_bib9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/bdrb.21089","article-title":"Placental transfer of Fc-containing biopharmaceuticals across species, an industry survey analysis","volume":"98","author":"Bowman","year":"2013","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/bdrb.21184","article-title":"Goldilocks' Determination of What New In Vivo Data are \"Just Right\" for Ddfferent Ccmmon Ddug Ddvelopment Ssenarios, Pprt 1","volume":"107","author":"Bowman","year":"2016","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/bdrb.20248","article-title":"Embryo-fetal developmental toxicity of figitumumab, an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in cynomolgus monkeys","volume":"89","author":"Bowman","year":"2010","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/bdrb.20223","article-title":"Development of a zebrafish embryo teratogenicity assay and quantitative prediction model","volume":"89","author":"Brannen","year":"2010","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19420862.2017.1389364","article-title":"Safety testing of monoclonal antibodies in non-human primates: case studies highlighting their impact on human risk assessment","volume":"10","author":"Brennan","year":"2018","journal-title":"mAbs"},{"key":"10.1016\/j.yrtph.2025.105971_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/bdrb.21147","article-title":"Developmental toxicity and fertility assessment in rabbits with tabalumab: a human IgG4 monoclonal antibody","volume":"104","author":"Breslin","year":"2015","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2023.105449","article-title":"Considerations regarding the use of nonhuman primates in assessing safety endpoints for pharmaceuticals","volume":"143","author":"Brown","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1191\/096032700678815783","article-title":"Preclinical development of keliximab, a primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studies","volume":"19","author":"Bugelski","year":"2000","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib17","first-page":"10","article-title":"Predictive power of preclinical studies in animals for the immunogenicity of recombinant therapeutic proteins in humans","volume":"6","author":"Bugelski","year":"2004","journal-title":"Curr. Opin. Mol. Therapeut."},{"key":"10.1016\/j.yrtph.2025.105971_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2010.09.017","article-title":"Survey results on the use of the tissue cross-reactivity immunohistochemistry assay","volume":"59","author":"Bussiere","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.yrtph.2013.05.002","article-title":"Assessment of menstrual cycle length in cynomolgus monkeys as a female fertility endpoint of a biopharmaceutical in a 6 month toxicity study","volume":"66","author":"Bussiere","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.reprotox.2013.07.018","article-title":"Reproductive toxicity of denosumab in cynomolgus monkeys","volume":"42","author":"Bussiere","year":"2013","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib21","first-page":"12","article-title":"Efavirenz pregnancy warning","volume":"12","author":"Cadman","year":"1998","journal-title":"GMHC Treat Issues"},{"key":"10.1016\/j.yrtph.2025.105971_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.reprotox.2013.06.061","article-title":"Sensitivity of male reproductive endpoints in nonhuman primate toxicity studies: a statistical power analysis","volume":"41","author":"Cappon","year":"2013","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.yrtph.2009.02.001","article-title":"A comparison of effects on reproduction and neonatal development in cynomolgus monkeys given human soluble IL-4R and mice given murine soluble IL-4R","volume":"53","author":"Carlock","year":"2009","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/toxsci\/kfae122","article-title":"An industry perspective on the FDA Modernization Act 2.0\/3.0: potential next steps for sponsors to reduce animal use in drug development","volume":"203","author":"Carratt","year":"2025","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105971_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.reprotox.2019.02.004","article-title":"A multi-institutional study benchmarking the zebrafish developmental assay for prediction of embryotoxic plasma concentrations from rat embryo-fetal development studies","volume":"86","author":"Cassar","year":"2019","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.reprotox.2020.10.002","article-title":"Knockout mouse models are predictive of malformations or embryo-fetal death in drug safety evaluations","volume":"99","author":"Catlin","year":"2021","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib28","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/bdr2.2019","article-title":"Quantitative in vitro to in vivo extrapolation for developmental toxicity potency of valproic acid analogues","volume":"114","author":"Chang","year":"2022","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.yrtph.2025.105971_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.yrtph.2011.10.016","article-title":"The design of chronic toxicology studies of monoclonal antibodies: implications for the reduction in use of non-human primates","volume":"62","author":"Chapman","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/bdrb.20216","article-title":"Developmental and reproductive toxicology studies in nonhuman primates","volume":"86","author":"Chellman","year":"2009","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2025.108927","article-title":"Immunogenicity-related placental infarcts and abortions in Nonhuman Primate developmental and reproductive toxicity studies: proposed mechanism and impact on study interpretation","author":"Chellman","year":"2025","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1124\/pr.110.002790","article-title":"The blood-testis barrier and its implications for male contraception","volume":"64","author":"Cheng","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.yrtph.2025.105971_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2024.105682","article-title":"The use of weight-of-evidence approaches to characterize developmental toxicity risk for therapeutic monoclonal antibodies in humans without in vivo studies","volume":"152","author":"Chien","year":"2024","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/bdrb.20115","article-title":"Evaluation of the developmental toxicity of lenalidomide in rabbits","volume":"80","author":"Christian","year":"2007","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.reprotox.2015.10.008","article-title":"Assessment of ixekizumab, an interleukin-17A monoclonal antibody, for potential effects on reproduction and development, including immune system function, in cynomolgus monkeys","volume":"58","author":"Clarke","year":"2015","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.reprotox.2020.02.011","article-title":"Predicting the safety of medicines in pregnancy: a workshop report","volume":"93","author":"Clements","year":"2020","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1152\/physrev.1972.52.1.198","article-title":"Kinetics of spermatogenesis in mammals: seminiferous epithelium cycle and spermatogonial renewal","volume":"52","author":"Clermont","year":"1972","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yrtph.2025.105971_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105796","article-title":"Report on the European partnership for alternative approaches to animal testing (EPAA) \"New Approach Methodologies (NAMs) User Forum Kick-Off Workshop\"","volume":"159","author":"Cronin","year":"2025","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2826.2008.01800.x","article-title":"Relationship between social rank and cortisol and testosterone concentrations in male cynomolgus monkeys (Macaca fascicularis)","volume":"21","author":"Czoty","year":"2009","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.yrtph.2025.105971_bib40","article-title":"Immune checkpoint inhibitor treatment does not impair ovarian or endocrine function in a mouse model of triple negative breast cancer","author":"De La Cruz","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.yrtph.2025.105971_bib41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s12951-024-02651-w","article-title":"Organ-on-a-chip: future of female reproductive pathophysiological models","volume":"22","author":"Deng","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.yrtph.2025.105971_bib42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/10408444.2011.653487","article-title":"The placenta, transfer of immunoglobulins, and safety assessment of biopharmaceuticals in pregnancy","volume":"42","author":"DeSesso","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/01926230701230346","article-title":"Spermatogenesis in the cynomolgus monkey (Macaca fascicularis): a practical guide for routine morphological staging","volume":"35","author":"Dreef","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2025.105971_bib44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1352458514546790","article-title":"Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study","volume":"21","author":"Ebrahimi","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.yrtph.2025.105971_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/bdrb.20263","article-title":"Whole embryo culture: a \"New\" technique that enabled decades of mechanistic discoveries","volume":"89","author":"Ellis-Hutchings","year":"2010","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib46","series-title":"Revlimid: European Public Assessment Report - Scientific Discussion","year":"2007"},{"key":"10.1016\/j.yrtph.2025.105971_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.anireprosci.2004.10.002","article-title":"Investigations on the expression of cytokines in the canine corpus luteum in relation to dioestrus","volume":"87","author":"Engel","year":"2005","journal-title":"Anim. Reprod. Sci."},{"key":"10.1016\/j.yrtph.2025.105971_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/bdrb.20179","article-title":"Comparative effects of interferon alpha-2b and pegylated interferon alpha-2b on menstrual cycles and ovarian hormones in cynomolgus monkeys","volume":"86","author":"Enright","year":"2009","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib49","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/bdrb.20287","article-title":"Developmental and reproductive toxicology studies in IL-12p40 knockout mice","volume":"92","author":"Enright","year":"2011","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/bdrb.21031","article-title":"Male and female fertility assessment in the cynomolgus monkey following administration of ABT-874, a human Anti-IL-12\/23p40 monoclonal antibody","volume":"95","author":"Enright","year":"2012","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib51","series-title":"Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the Protection of Animals Used for Scientific Purposes (Text with EEA Relevance)Text with EEA Relevance","year":"2010"},{"key":"10.1016\/j.yrtph.2025.105971_bib53","series-title":"Guidance for Industry: Oncology Pharmaceuticals: Reproductive Toxicity Testing and Labeling Recommendations","year":"2019"},{"key":"10.1016\/j.yrtph.2025.105971_bib58","article-title":"Nonclinical considerations for mitigating nonhuman primate supply constraints arising from the COVID-19 pandemic","year":"2022","journal-title":"Guidance Industry"},{"key":"10.1016\/j.yrtph.2025.105971_bib75","article-title":"Checkpoint inhibitors, fertility, pregnancy, and sexual life: a systematic review","volume":"6","author":"Garutti","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.yrtph.2025.105971_bib76","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/026119290403200305","article-title":"Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests","volume":"32","author":"Genschow","year":"2004","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.yrtph.2025.105971_bib77","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/bcp.14145","article-title":"The pre- and post-authorisation data published by the European medicines agency on the use of biologics during pregnancy and lactation","volume":"86","author":"Ghalandari","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib78","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.reprotox.2020.04.074","article-title":"Enhanced normograms and pregnancy outcome analysis in nonhuman primate developmental toxicity studies","volume":"95","author":"Grossmann","year":"2020","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib79","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70049","article-title":"On placental and lactational transfer of IgG-based therapeutic proteins - current understanding and knowledge gaps from a clinical pharmacology perspective","volume":"17","author":"Guinn","year":"2024","journal-title":"Clin Transl. Sci."},{"key":"10.1016\/j.yrtph.2025.105971_bib80","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/andr.13546","article-title":"Testicular function after non-cytotoxic and immunotherapy drug treatment","volume":"12","author":"Handelsman","year":"2024","journal-title":"Andrology"},{"key":"10.1016\/j.yrtph.2025.105971_bib81","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfaf132","article-title":"In vitro models of the male reproductive system: applications for developmental and reproductive toxicology","author":"Hansen","year":"2025","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105971_bib82","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1191\/0960327102ht289oa","article-title":"Practical aspects of including functional endpoints in developmental toxicity studies. Case study: immune function in HuCD4 transgenic mice exposed to anti-CD4 MAb in utero","volume":"21","author":"Herzyk","year":"2002","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib83","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.reprotox.2019.10.007","article-title":"\"Simulect\" as a model compound for assessing placental transfer of monoclonal antibodies in minipigs","volume":"91","author":"Hey","year":"2020","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib84","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/bdrb.21182","article-title":"TGF-beta1 monoclonal antibody: assessment of embryo-fetal toxicity in rats and rabbits","volume":"107","author":"Hilbish","year":"2016","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib85","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/nat.2020.0879","article-title":"Considerations of the Japanese research working group for the ICH S6 & related issues regarding nonclinical safety assessments of oligonucleotide therapeutics: Comparison with those of biopharmaceuticals","volume":"31","author":"Hirabayashi","year":"2021","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.yrtph.2025.105971_bib86","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/10915818231200859","article-title":"Alternatives to monkey reproductive toxicology testing for biotherapeutics","volume":"42","author":"Hoberman","year":"2023","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib87","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.reprotox.2022.10.005","article-title":"Embryo-fetal exposure and developmental outcome of lenalidomide following oral administration to pregnant cynomolgus monkeys","volume":"114","author":"Hui","year":"2022","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib89","series-title":"Guidance on Detection of Reproductive and Developmental Toxicity for Human Pharmaceuticals","year":"2020"},{"key":"10.1016\/j.yrtph.2025.105971_bib90","series-title":"Guidance on Preclinical Safety Evaluation of biotechnology-derived Pharmaceuticals","year":"2011"},{"key":"10.1016\/j.yrtph.2025.105971_bib91","series-title":"Nonclinical Evaluation for Anticancer Pharmaceuticals","year":"2009"},{"key":"10.1016\/j.yrtph.2025.105971_bib92","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/0192623315610821","article-title":"FcRn expression on placenta and fetal Jejunum during early, Mid-, and late gestation in minipigs","volume":"44","author":"Jacobsen","year":"2016","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2025.105971_bib93","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/bdr2.2001","article-title":"A novel human stem cell-based biomarker assay for in vitro assessment of developmental toxicity","volume":"114","author":"Jamalpoor","year":"2022","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.yrtph.2025.105971_bib94","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.yrtph.2007.11.007","article-title":"A retrospective analysis of developmental toxicity studies in rat and rabbit: what is the added value of the rabbit as an additional test species?","volume":"50","author":"Janer","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib95","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/bdrb.20234","article-title":"The cynomolgus monkey as a model for developmental toxicity studies: variability of pregnancy losses, statistical power estimates, and group size considerations","volume":"89","author":"Jarvis","year":"2010","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib97","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jbiosc.2021.12.006","article-title":"Integrated fibroblast growth factor signal disruptions in human iPS cells for prediction of teratogenic toxicity of chemicals","volume":"133","author":"Kanno","year":"2022","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.yrtph.2025.105971_bib98","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s10815-019-01572-0","article-title":"Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal","volume":"36","author":"Kirshenbaum","year":"2019","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.yrtph.2025.105971_bib99","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.vascn.2009.10.006","article-title":"A simple orchidometric method for the preliminary assessment of maturity status in male cynomolgus monkeys (Macaca fascicularis) used for nonclinical safety studies","volume":"61","author":"Ku","year":"2010","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.yrtph.2025.105971_bib100","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1177\/0961203311409272","article-title":"Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using Anti-Muellerian hormone","volume":"20","author":"Lawrenz","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.yrtph.2025.105971_bib101","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1177\/0192623310382559","article-title":"Use of tissue cross-reactivity studies in the development of antibody-based biopharmaceuticals: history, experience, methodology, and future directions","volume":"38","author":"Leach","year":"2010","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2025.105971_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105902","article-title":"Considerations of non-human primate use in nonclinical toxicity study package for oncology therapeutics with well-characterized target in supports of 3Rs - an IQ DruSafe industry survey","volume":"162","author":"Leung","year":"2025","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105814","article-title":"Enhanced pre- and postnatal developmental toxicity (ePPND) study in non-human primates: necessity, strategic approaches, and critical considerations","volume":"159","author":"Lu","year":"2025","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5194\/pb-7-1-2020","article-title":"Group size experiences with enhanced pre- and postnatal development studies in the long-tailed macaque (Macaca fascicularis)","volume":"7","author":"Luetjens","year":"2020","journal-title":"Primate Biol."},{"key":"10.1016\/j.yrtph.2025.105971_bib105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.yrtph.2012.05.003","article-title":"Functional assessment of sexual maturity in male macaques (Macaca fascicularis)","volume":"63","author":"Luetjens","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib106","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/bdr2.1403","article-title":"PDGFRalpha monoclonal antibody: assessment of embryo-fetal toxicity and time-dependent placental transfer of a murine surrogate antibody of olaratumab in mice","volume":"110","author":"Luffer-Atlas","year":"2018","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.yrtph.2025.105971_bib107","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/10915810802368196","article-title":"Effects of administration of a monoclonal antibody against mouse tumor necrosis factor alpha during pregnancy and lactation on the pre- and postnatal development of the mouse immune system","volume":"27","author":"Martin","year":"2008","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib108","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/bdrb.20227","article-title":"Effects of CNTO 530, an erythropoietin mimetic-IgG4 fusion protein, on embryofetal development in rats and rabbits","volume":"89","author":"Martin","year":"2010","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib109","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/1091581810378896","article-title":"Developmental toxicity testing of biopharmaceuticals in nonhuman primates: previous experience and future directions","volume":"29","author":"Martin","year":"2010","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/10915818221101791","article-title":"Increasing the reuse of protein non-naive nonhuman Primates in pharmaceutical drug discovery and development: an overview and industry position on the challenges and benefits","volume":"41","author":"Mattis","year":"2022","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib111","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0192623319831009","article-title":"Toxicologic pathology forum\u2217: opinion on sexual maturity and fertility assessment in long-tailed macaques (Macaca fascicularis) in nonclinical safety studies","volume":"47","author":"Mecklenburg","year":"2019","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2025.105971_bib112","article-title":"A COVID-19 vaccine: big strides come with big challenges","volume":"9","author":"Mellet","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.yrtph.2025.105971_bib113","series-title":"Interpreting Menstrual Cycling in Nonhuman Primate Reproductive Toxicology Studies: Need for Ovarian Hormone Data. Teratology Society, San Diego, CA","author":"Meyer","year":"2011"},{"key":"10.1016\/j.yrtph.2025.105971_bib114","article-title":"Utility of orchidometric parameters for assessing sexual maturation in Male cynomolgus macaques (Macaca fascicularis)","volume":"66","author":"Mirsky","year":"2016","journal-title":"Comp. Med."},{"key":"10.1016\/j.yrtph.2025.105971_bib115","doi-asserted-by":"crossref","DOI":"10.1095\/biolreprod.110.087452","article-title":"The blood-testis and blood-epididymis barriers are more than just their tight junctions","volume":"84","author":"Mital","year":"2011","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.yrtph.2025.105971_bib116","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/bdrb.21105","article-title":"Placental transfer of a fully human IgG2 monoclonal antibody in the cynomolgus monkey, rat, and rabbit: a comparative assessment from during organogenesis to late gestation","volume":"101","author":"Moffat","year":"2014","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib117","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3899\/jrheum.131360","article-title":"Reduced ovarian reserve in patients with Takayasu arteritis","volume":"41","author":"Mont'Alverne","year":"2014","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.yrtph.2025.105971_bib118","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10067-014-2680-5","article-title":"Diminished ovarian reserve in Behcet's disease patients","volume":"34","author":"Mont'Alverne","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.yrtph.2025.105971_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2023.153684","article-title":"Animal-free assessment of developmental toxicity: combining PBPK modeling with the ReproTracker assay","volume":"500","author":"Moreau","year":"2023","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2025.105971_bib120","series-title":"Nonhuman Primate Models in Biomedical Research: State of the Science and Future Needs","year":"2023"},{"key":"10.1016\/j.yrtph.2025.105971_bib121","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.reprotox.2009.09.007","article-title":"Effects of social housing of sexually mature male cynomolgus monkeys during general and reproductive toxicity evaluation","volume":"29","author":"Niehoff","year":"2010","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib122","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1095\/biolreprod17.4.532","article-title":"Duration of the cycle of the seminiferous epithelium in the Guinea pig determined by tritiated thymidine autoradiography","volume":"17","author":"Noller","year":"1977","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.yrtph.2025.105971_bib123","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.reprotox.2011.10.018","article-title":"Zebrafish developmental screening of the ToxCast Phase I chemical library","volume":"33","author":"Padilla","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib124","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/bdrb.21078","article-title":"Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening","volume":"98","author":"Palmer","year":"2013","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib125","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/toxsci\/kfs293","article-title":"Establishment of a molecular embryonic stem cell developmental toxicity assay","volume":"131","author":"Panzica-Kelly","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105971_bib126","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/bdrb.20148","article-title":"Assessment of the Embryonic Stem Cell Test and application and use in the pharmaceutical industry","volume":"83","author":"Paquette","year":"2008","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib127","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s13770-023-00617-x","article-title":"Effects of cetrorelix on ovary and endometrium prior to Anti-PD-L1 antibody in Murine model","volume":"21","author":"Park","year":"2024","journal-title":"Tissue Eng. Regen Med."},{"key":"10.1016\/j.yrtph.2025.105971_bib128","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-0684.1997.tb00222.x","article-title":"Frequency of spontaneous congenital defects in rhesus and cynomolgus macaques","volume":"26","author":"Peterson","year":"1997","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.yrtph.2025.105971_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.crtox.2022.100074","article-title":"Pluripotent stem cell assays: modalities and applications for predictive developmental toxicity","volume":"3","author":"Piersma","year":"2022","journal-title":"Curr. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/026119290403200307","article-title":"Validation of the postimplantation rat whole-embryo culture test in the international ECVAM validation study on three in vitro embryotoxicity tests","volume":"32","author":"Piersma","year":"2004","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.yrtph.2025.105971_bib131","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.yrtph.2009.03.012","article-title":"Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies","volume":"54","author":"Ponce","year":"2009","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103242","article-title":"GSK2245035, a TLR7 agonist, does not increase pregnancy loss in cynomolgus monkeys","volume":"143","author":"Posobiec","year":"2021","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.yrtph.2025.105971_bib133","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/bdrb.21176","article-title":"An evaluation of the impact of PD-1 pathway blockade on reproductive safety of therapeutic PD-1 inhibitors","volume":"107","author":"Poulet","year":"2016","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib134","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1091581815625596","article-title":"Perspective on a modified developmental and reproductive toxicity testing strategy for cancer immunotherapy","volume":"35","author":"Prell","year":"2016","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.21037\/atm.2020.02.106","article-title":"Tissue cross-reactivity studies of CPGJ701 in humans, cynomolgus monkeys and Sprague-Dawley rats and correlation analysis with in vivo toxicity","volume":"8","author":"Qu","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.yrtph.2025.105971_bib136","first-page":"864","article-title":"A retrospective analysis of fertility assessments for monoclonal antibodies in sexually mature nonhuman Primates (P59)","volume":"115","author":"Rayhon","year":"2023","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.yrtph.2025.105971_bib137","doi-asserted-by":"crossref","DOI":"10.1095\/biolreprod27.2.354","article-title":"The pubescent rhesus monkey: some characteristics of the menstrual cycle","volume":"27","author":"Resko","year":"1982","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.yrtph.2025.105971_bib138","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ad618f","article-title":"Spermatogenesis in mouse testicular organoids with testis-specific architecture, improved germ cell survival and testosterone production","volume":"16","author":"Richer","year":"2024","journal-title":"Biofabrication"},{"key":"10.1016\/j.yrtph.2025.105971_bib139","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.yrtph.2018.07.006","article-title":"Applying a weight of evidence approach to the evaluation of developmental toxicity of biopharmaceuticals","volume":"98","author":"Rocca","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105971_bib140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/bdrb.20188","article-title":"The Guinea pig as an animal model for developmental and reproductive toxicology studies","volume":"86","author":"Rocca","year":"2009","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib141","article-title":"Retrospective Evaluation of the Use of Non-human Primates for Fertility Assessment of Pharmaceuticals Submitted for Marketing Approval in the EU","volume":"105967","author":"Roos","year":"2025","journal-title":"Regul. Toxicol. Pharmacol.","ISSN":"https:\/\/id.crossref.org\/issn\/0273-2300","issn-type":"print"},{"key":"10.1016\/j.yrtph.2025.105971_bib142","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-3565(25)27910-1","article-title":"A comparison of the teratogenic activity of thalidomide in rabbits and rats","volume":"160","author":"Schumacher","year":"1968","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.yrtph.2025.105971_bib143","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaoncol.2020.1641","article-title":"Association of impaired spermatogenesis with the use of immune checkpoint inhibitors in patients with metastatic Melanoma","volume":"6","author":"Scovell","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.yrtph.2025.105971_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104328","article-title":"Opportunities and insights from pharmaceutical companies on the current use of new approach methodologies in nonclinical safety assessment","volume":"30","author":"Shenton","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.yrtph.2025.105971_bib145","article-title":"In vitro models for gonadal and placental toxicity: a review and industry survey","volume":"1","author":"Silva","year":"2025","journal-title":"NAMTA J."},{"key":"10.1016\/j.yrtph.2025.105971_bib146","first-page":"18","article-title":"Methods for predicting sexual maturity in male cynomolgus macaques on the basis of age, body weight, and histologic evaluation of the testes","volume":"41","author":"Smedley","year":"2002","journal-title":"Contemp. Top. Lab. Anim. Sci."},{"key":"10.1016\/j.yrtph.2025.105971_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.721130","article-title":"Validation, optimization, and application of the zebrafish developmental toxicity assay for pharmaceuticals under the ICH S5(R3) Guideline","volume":"9","author":"Song","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yrtph.2025.105971_bib148","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/026119290403200306","article-title":"Validation of the rat limb bud micromass test in the international ECVAM validation study on three in vitro embryotoxicity tests","volume":"32","author":"Spielmann","year":"2004","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.yrtph.2025.105971_bib149","first-page":"343","article-title":"Introducing the concept of virtual control groups into preclinical toxicology testing","volume":"37","author":"Steger-Hartmann","year":"2020","journal-title":"ALTEX"},{"key":"10.1016\/j.yrtph.2025.105971_bib150","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1210\/endo-109-3-914","article-title":"Endocrine correlates of sexual development in the male monkey, Macaca fascicularis","volume":"109","author":"Steiner","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.yrtph.2025.105971_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdrb.10054","article-title":"Effects of thalidomide on reproductive function and early embryonic development in male and female New Zealand white rabbits","volume":"71","author":"Teo","year":"2004","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib152","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/bdr2.1542","article-title":"Allogeneic murine pregnancy models for assessing the developmental effects of immune-stimulating antibodies: challenges in reproducibility","volume":"111","author":"Thompson","year":"2019","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.yrtph.2025.105971_bib153","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/bdrb.20289","article-title":"Not a walk in the park: the ECVAM whole embryo culture model challenged with pharmaceuticals and attempted improvements with random forest design","volume":"92","author":"Thomson","year":"2011","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib154","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jmp.12528","article-title":"China is facing serious experimental monkey shortage during the COVID-19 lockdown","volume":"50","author":"Tian","year":"2021","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.yrtph.2025.105971_bib155","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/1097-0142(19860415)57:8+<1648::AID-CNCR2820571303>3.0.CO;2-O","article-title":"The preclinical development of Roferon-A","volume":"57","author":"Trown","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.yrtph.2025.105971_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104064","article-title":"Immune checkpoint inhibitors as a threat to reproductive function: a systematic review","volume":"188","author":"Tuerxun","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.yrtph.2025.105971_bib157","series-title":"Public Law 117 - 328 -Consolidated Appropriations Act, 2023","year":"2023"},{"key":"10.1016\/j.yrtph.2025.105971_bib158","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1177\/0192623321990631","article-title":"Scientific and regulatory policy committee best practices: documentation of sexual maturity by microscopic evaluation in nonclinical safety studies","volume":"49","author":"Vidal","year":"2021","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2025.105971_bib159","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/humrep\/del217","article-title":"Ovarian follicular concentration of IL-12, IL-15, IL-18 and p40 subunit of IL-12 and IL-23","volume":"21","author":"Vujisic","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.yrtph.2025.105971_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2023.108362","article-title":"A dynamic in vitro developing testis model reflects structures and functions of testicular development in vivo","volume":"118","author":"Wegner","year":"2023","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib161","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/bdrb.20189","article-title":"Effects of natalizumab, an alpha4 integrin inhibitor, on the development of Hartley Guinea pigs","volume":"86","author":"Wehner","year":"2009","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib162","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/bdrb.20191","article-title":"Effects of natalizumab, an alpha4 integrin inhibitor, on fertility in male and female Guinea pigs","volume":"86","author":"Wehner","year":"2009","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib163","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/bdrc.20220","article-title":"The enhanced pre- and postnatal study for nonhuman primates: update and perspectives","volume":"93","author":"Weinbauer","year":"2011","journal-title":"Birth Defects Res. C Embryo Today"},{"key":"10.1016\/j.yrtph.2025.105971_bib164","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1177\/0192623308327412","article-title":"Physiology and endocrinology of the ovarian cycle in macaques","volume":"36","author":"Weinbauer","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2025.105971_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2023.108513","article-title":"Validation of a zebrafish developmental defects assay as a qualified alternative test for its regulatory use following the ICH S5(R3) guideline","volume":"123","author":"Weiner","year":"2024","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43018-022-00413-x","article-title":"Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in mice","volume":"3","author":"Winship","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.yrtph.2025.105971_bib167","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/JOE-21-0209","article-title":"Effects of PD-1 blockade on ovarian follicles in a prepubertal female mouse","volume":"252","author":"Xu","year":"2021","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.yrtph.2025.105971_bib168","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/0961203314529468","article-title":"Ovarian reserve in women with primary antiphospholipid syndrome","volume":"23","author":"Yamakami","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.yrtph.2025.105971_bib169","doi-asserted-by":"crossref","first-page":"e804","DOI":"10.1016\/S2214-109X(18)30218-3","article-title":"Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study","volume":"6","author":"Zash","year":"2018","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.yrtph.2025.105971_bib170","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/acs.chemrestox.5b00458","article-title":"In vitro developmental toxicology screens: a report on the progress of the methodology and future applications","volume":"29","author":"Zhang","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105971_bib171","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/toxsci\/kfs112","article-title":"Development of a streamlined rat whole embryo culture assay for classifying teratogenic potential of pharmaceutical compounds","volume":"127","author":"Zhang","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105971_bib172","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/aps.2012.51","article-title":"Clinical pharmacology considerations in biologics development","volume":"33","author":"Zhao","year":"2012","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323002500203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323002500203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:04:24Z","timestamp":1773295464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027323002500203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":148,"alternative-id":["S027323002500203X"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2025.105971","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimizing use of nonhuman primates to inform risk to fertility and of adverse pregnancy outcomes with pharmaceuticals","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2025.105971","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105971"}}